Cite
HARVARD Citation
Clamp, A. et al. (n.d.). 943PDResponse to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment. Annals of oncology. p. . [Online].